Benalmádena
Benalmádena introduces two drugs that slow early Alzheimer's
Vithas Xanit Hospital in Benalmádena adds donanemab and lecanemab, two intravenous drugs that slow early Alzheimer's, without public funding.
Latest Donanemab news
2 articles
CEAFA's president, Mariló Almagro, demands funding for lecanemab and donanemab, which slow Alzheimer's by 18 months. Women bear 82% of care.
Vithas Xanit Hospital in Benalmádena adds donanemab and lecanemab, two intravenous drugs that slow early Alzheimer's, without public funding.